067370 선바이오
기본 정보
- 섹터: KOSDAQ:제조
- 시가총액: 782억원 (2026-06-30 기준)
- 첫 등장: 2026-06-18 (누적 1일)
- 태그: 매크로/바이오헬스 · 바이오시밀러 · PEG · 바이오신약 · 의료기기
- 네이버 금융: 🔗
기업개요
- 동사는 1997년 설립된 PEG 유도체 소재 및 PEGylation 기술 기반 바이오신약, 의료기기 개발 전문기업임.
- 호중구감소증 치료제 Pegfilgrastim 바이오시밀러를 EU, 캐나다, 호주, 인도 등에서 판매 중이고, 구강건조증 치료제 MucoPEG은 미국 FDA 판매허가를 받았음.
- 2024년 본사 및 GMP공장 준공 후 2025년 통합 이전을 완료하여 생산 최적화 및 고부가가치 제품 양산 체제를 구축하고 있음.
출처: 네이버증권 종목분석 (WiseReport)
일자별 등장 (최신 위, 누적)
| 일자 | 전일 종가 | 종가 | 등락률 | 시간외 | vol | 색깔 | smart | 외 | 연 | 금투 | 투 | 개 | 그외 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-10 | 6,100 | 5,810 | 🔵 -4.75% | — | ×0.2 | 🔻 개인 | -0.4억 | -0.4 | +0.0 | +0.0 | +0.4 | +0.0 | |
| 2026-07-09 | 5,990 | 6,100 | 🔴 +1.84% | — | ×0.1 | 🟢 외인 | +0.2억 | +0.2 | +0.0 | +0.0 | -0.2 | -0.0 | |
| 2026-07-08 | 6,120 | 5,990 | 🔵 -2.12% | — | ×0.3 | 🔻 개인 | -1.1억 | -1.1 | +0.0 | +0.0 | +1.1 | +0.0 | |
| 2026-07-07 | 6,400 | 6,120 | 🔵 -4.38% | — | ×0.4 | 🟢 외인 | +0.6억 | +0.6 | +0.0 | +0.0 | -0.6 | -0.0 | |
| 2026-07-06 | 6,630 | 6,400 | 🔵 -3.47% | — | ×0.1 | 🟢 외인 | +0.3억 | +0.3 | +0.0 | +0.0 | -0.4 | +0.1 | |
| 2026-07-03 | 6,610 | 6,630 | 🔴 +0.30% | — | ×0.1 | ⚫ 그외 | -0.1억 | -0.1 | +0.0 | -0.0 | -0.2 | +0.3 | |
| 2026-07-02 | 6,610 | 6,610 | ⚪ +0.00% | — | ×0.1 | ⚫ 그외 | -0.1억 | -0.1 | +0.0 | +0.0 | -0.2 | +0.3 | |
| 2026-07-01 | 6,410 | 6,610 | 🔴 +3.12% | — | ×0.1 | ⚫ 그외 | -0.1억 | -0.1 | +0.0 | +0.0 | -0.1 | +0.2 | |
| 2026-06-30 | 6,260 | 6,410 | 🔴 +2.40% | — | ×0.1 | ⚫ 그외 | -0.0억 | -0.0 | +0.0 | +0.0 | -0.1 | +0.1 | |
| 2026-06-29 | 6,060 | 6,260 | 🔴 +3.30% | — | ×0.1 | ⚫ 그외 | +0.0억 | +0.0 | +0.0 | +0.0 | -0.1 | +0.1 | |
| 2026-06-26 | 6,170 | 6,060 | 🔵 -1.78% | — | ×0.3 | 🟢 외인 | +0.4억 | +0.4 | +0.0 | +0.0 | -0.4 | +0.0 | |
| 2026-06-25 | 6,150 | 6,170 | 🔴 +0.33% | — | ×0.1 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.1 | +0.0 | |
| 2026-06-24 | 6,030 | 6,150 | 🔴 +1.99% | — | ×0.3 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.1 | -0.1 | |
| 2026-06-23 | 7,130 | 6,030 | 🔵 -15.43% | — | ×0.5 | 🔻 개인 | -0.5억 | -0.5 | +0.0 | +0.0 | +0.6 | -0.0 | |
| 2026-06-22 | 7,220 | 7,130 | 🔵 -1.25% | — | ×1.0 | ⚫ 그외 | +0.3억 | +0.3 | +0.0 | +0.0 | -1.6 | +1.3 | |
| 2026-06-19 | 7,390 | 7,220 | 🔵 -2.30% | — | ×5.7 | ⚫ 그외 | -0.7억 | -0.7 | +0.0 | +0.0 | -1.8 | +2.5 | |
| 2026-06-18 | 5,690 | 7,390 | 🔴 +29.88% | — | ×58.3 | 🔻 개인 | -1.5억 | -1.5 | +0.0 | +0.0 | +4.8 | -3.3 | |
| 2026-06-17 | 5,680 | 5,690 | 🔴 +0.18% | — | ×0.2 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | +0.0 | -0.0 | +0.0 | |
| 2026-06-16 | 5,980 | 5,680 | 🔵 -5.02% | — | ×0.8 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.1 | +0.0 | |
| 2026-06-15 | 5,810 | 5,980 | 🔴 +2.93% | — | ×0.6 | ⚫ 그외 | +0.0억 | +0.0 | +0.0 | +0.0 | -0.0 | +0.0 | |
| 2026-06-12 | 5,810 | 5,810 | ⚪ +0.00% | — | ×0.6 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.0 | +0.0 | |
| 2026-06-11 | 5,990 | 5,810 | 🔵 -3.01% | — | ×1.2 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | -0.1 | +0.0 | |
| 2026-06-10 | 6,030 | 5,990 | 🔵 -0.66% | — | ×0.5 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | -0.1 | +0.0 | |
| 2026-06-09 | 5,660 | 6,030 | 🔴 +6.54% | — | ×0.5 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | -0.1 | +0.0 | |
| 2026-06-08 | 6,210 | 5,660 | 🔵 -8.86% | — | ×1.2 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.2 | +0.0 | |
| 2026-06-05 | 6,650 | 6,210 | 🔵 -6.62% | — | ×0.2 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.1 | +0.0 | |
| 2026-06-04 | 6,580 | 6,650 | 🔴 +1.06% | — | ×1.3 | 🔻 개인 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.1 | -0.2 | |
| 2026-06-02 | 6,590 | 6,580 | 🔵 -0.15% | — | ×1.2 | ⚫ 그외 | -0.1억 | -0.1 | +0.0 | +0.0 | -0.4 | +0.5 | |
| 2026-06-01 | 6,190 | 6,590 | 🔴 +6.46% | — | ×1.5 | ⚫ 그외 | -0.2억 | -0.2 | +0.0 | +0.0 | -0.5 | +0.7 | |
| 2026-05-29 | 6,270 | 6,190 | 🔵 -1.28% | — | ×0.7 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.2 | -0.0 | |
| 2026-05-28 | 6,140 | 6,270 | 🔴 +2.12% | — | ×0.3 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | +0.0 | -0.0 | +0.0 | |
| 2026-05-27 | 6,130 | 6,140 | 🔴 +0.16% | — | ×0.3 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.1 | +0.1 | |
| 2026-05-26 | 6,660 | 6,130 | 🔵 -7.96% | — | ×1.0 | 🟢 외인 | +0.3억 | +0.3 | +0.0 | +0.0 | +0.0 | -0.3 | |
| 2026-05-22 | 6,400 | 6,660 | 🔴 +4.06% | — | ×0.3 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | -0.2 | +0.1 |
일자별 사유 (최신 위)
2026-06-18
- 사유: —
- 섹터 컨텍스트: KOSDAQ:제조 (smart -813억)
- 매크로 원인: BIO USA 2026 컨퍼런스 개막에 제약·바이오 투자심리 회복, 항암 신약 모멘텀 부각 (보통)